Fig. 2. Kaplan–Meier plot of overall survival in 14 gemcitabine-refractory patients treated with 3-aminopyridine-2-carboxaldehyde thiosemicarbazone.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.